Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CervoMed (CRVO)
NASDAQ:CRVO
CervoMed (CRVO) Stock Price & Analysis
728 Followers
CRVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.14 - $26.38
Previous Close$15.87
Volume19.74K
Average Volume (3M)48.68K
Market Cap
$130.82M
Enterprise Value$124.45M
Total Cash (Recent Filing)$6.37M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.15
Next Earnings
May 15, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.08
Shares Outstanding8,253,741
10 Day Avg. Volume76,007
30 Day Avg. Volume48,684
Standard Deviation0.34
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)30.81
Price to Sales (P/S)23.01
Price to Cash Flow (P/CF)-28.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.29
Enterprise Value/Gross Profit17.42
Enterprise Value/Ebitda182.08
Forecast
1Y Price Target
$67.50Price Target Upside325.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
CervoMed News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CRVO FAQ
What was CervoMed’s price range in the past 12 months?
CervoMed lowest stock price was $4.14 and its highest was $26.38 in the past 12 months.
What is CervoMed’s market cap?
Currently, no data Available
When is CervoMed’s upcoming earnings report date?
CervoMed’s upcoming earnings report date is May 15, 2024 which is 50 days ago.
How were CervoMed’s earnings last quarter?
CervoMed released its earnings results on Apr 01, 2024. The company reported -$0.41 earnings per share for the quarter, missing the consensus estimate of -$0.39 by -$0.02.
Is CervoMed overvalued?
According to Wall Street analysts CervoMed’s price is currently Undervalued.
Does CervoMed pay dividends?
CervoMed does not currently pay dividends.
What is CervoMed’s EPS estimate?
CervoMed’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CervoMed have?
CervoMed has 8,253,741 shares outstanding.
What happened to CervoMed’s price movement after its last earnings report?
CervoMed reported an EPS of -$0.41 in its last earnings report, missing expectations of -$0.39. Following the earnings report the stock price went up 0.081%.
Which hedge fund is a major shareholder of CervoMed?
Among the largest hedge funds holding CervoMed’s share is RA Capital Management. It holds CervoMed’s shares valued at 20M.
---
CervoMed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$67.50 (325.33% Upside)
$67.50 (325.33% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
230.62%
12-Months-Change
Fundamentals
Return on Equity
-44.78%
Trailing 12-Months
Asset Growth
-56.55%
Trailing 12-Months
Company Description
CervoMed
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate, for use in those life threatening conditions in which cellular oxygen deprivation is the basis for significant unmet medical needs. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
---
CRVO Stock 12 Month Forecast
Average Price Target
$67.50
▲(325.33% Upside)
Technical Analysis
Best Analysts Covering CRVO
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
-17.13%
reiterated a buy rating 2 months ago
Copying Sumant Kulkarni's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -17.13% per trade.
---